Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

LSD1 Inhibition Enhances Antigen Presentation and Co-Stimulation in AML to Promote T Cell-Mediated Anti-Leukemia Immune Responses

Yu Yan, Kanwaldeep Singh, Emily Hartung, Brendan Lee, Pradhariny Prabagaran, Dina Khalaf, Alejandro Garcia-Horton, Brian Leber, Irwin Walker, Kylie L. Lepic, Maria Kleppe, Hugh Young Young Rienhoff Jr., Jr., Jonathan Bramson, Tobias Berg

Blood (2023) 142 (Supplement 1): 6793.

https://doi.org/10.1182/blood-2023-188472

Published: 2023

Journal Articles

Tonic Signaling Leads to Off-Target Activation of T Cells Engineered with Chimeric Antigen Receptors That Is Not Seen in T Cells Engineered with T Cell Antigen Coupler (TAC) Receptors

Duane Moogk, Arya Afsahi, MSc, Vivian Lau, MSc, Anna Dvorkin-Gheva, PhD, Jonathan Bramson, PhD

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-141925

Published: 2020

Journal Articles

T Cells Engineered with T Cell Antigen Coupler (TAC) Receptors for Haematological Malignancies

Christopher Helsen, PhD, Vivian Lau, MSc, Joanne Hammill, PhD, Kenneth Mwawasi, MSc, Danielle Hayes, Arya Afsahi, MSc, Ksenia Bezverbnaya, MSc, Craig Aarts, MSc, Galina Denisova, PhD, Jonathan Bramson, PhD

Blood (2018) 132 (Supplement 1): 3267.

https://doi.org/10.1182/blood-2018-99-119045

Published: 2018

Journal Articles

T Cells Engineered with a Novel Chimeric Receptor Demonstrate Durable In Vivo Efficacy Against Disseminated Multiple Myeloma

Ksenia Bezverbnaya, BSc, Vivian Lau, MSc, Craig Aarts, MSc, Galina Denisova, PhD, Arya Afsahi, MSc, Carole Evelegh, BSc, Derek Cummings, BSc, Christopher Helsen, PhD, Jonathan Bramson, PhD

Blood (2018) 132 (Supplement 1): 962.

https://doi.org/10.1182/blood-2018-99-118569

Published: 2018

Journal Articles

Protection from endotoxemia by adenoviral-mediated gene transfer of human bactericidal/permeability-increasing protein

Scott Alexander, Jonathan Bramson, Ronan Foley, Zhou Xing

Blood (2004) 103 (1): 93–99.

https://doi.org/10.1182/blood-2003-02-0660

Published: 2004

NARROW

LSD1 Inhibition Enhances Antigen Presentation and Co-Stimulation in AML to Promote T Cell-Mediated Anti-Leukemia Immune Responses

Tonic Signaling Leads to Off-Target Activation of T Cells Engineered with Chimeric Antigen Receptors That Is Not Seen in T Cells Engineered with T Cell Antigen Coupler (TAC) Receptors

T Cells Engineered with T Cell Antigen Coupler (TAC) Receptors for Haematological Malignancies

T Cells Engineered with a Novel Chimeric Receptor Demonstrate Durable In Vivo Efficacy Against Disseminated Multiple Myeloma

Protection from endotoxemia by adenoviral-mediated gene transfer of human bactericidal/permeability-increasing protein

Email alerts

ASH Publications

American Society of Hematology

LSD1 Inhibition Enhances Antigen Presentation and Co-Stimulation in AML to Promote T Cell-Mediated Anti-Leukemia Immune Responses

Tonic Signaling Leads to Off-Target Activation of T Cells Engineered with Chimeric Antigen Receptors That Is Not Seen in T Cells Engineered with T Cell Antigen Coupler (TAC) Receptors

T Cells Engineered with T Cell Antigen Coupler (TAC) Receptors for Haematological Malignancies

T Cells Engineered with a Novel Chimeric Receptor Demonstrate Durable In Vivo Efficacy Against Disseminated Multiple Myeloma

Protection from endotoxemia by adenoviral-mediated gene transfer of human bactericidal/permeability-increasing protein

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only